RevHealth appoints Stacey Crowley to lead agency growth
Crowley has been appointed to the newly created role of senior VP, growth. The announcement continues the agency’s positive momentum as it solidifies its strong leadership bench.
New Search
If you are not happy with the results below please do another search
Search
50 search results for:
Eli Lilly lifts sales view by $2 billion on soaring weight-loss drug demand
/in Business, Therapeutics/by Reuters HealthLilly said it expects the drugs to remain in tight supply, but plans for significant production increases in the second half of the year.
Doceree elevates healthcare affordability with Co-Pay Spark launch
/in Marketing & Advertising/by AdministratorThe solution designed to enhance patient affordability and medication adherence by reaching the most influential stakeholder in health care – the healthcare professional, who lacks awareness of Patient affordability programs. Co-Pay Spark empowers HCPs to ignite awareness of and access to assistance programs for the patients who need them most, ultimately leading to improved adherence and better health outcomes.
Pfizer, Genmab’s ADC Tivdak scores full FDA approval in recurrent or metastatic cervical cancer
/in Therapeutics/by BioSpaceBased on strong overall and progression-free survival data in its Phase III confirmatory study, Pfizer and Genmab’s antibody-drug conjugate Tivdak on Monday secured the FDA’s full approval for recurrent or metastatic cervical cancer that had progressed on or after chemotherapy.
AstraZeneca, Daiichi Sankyo continue earlier-line breast cancer push with Phase III Enhertu win
/in R&D, Therapeutics/by BioSpaceAstraZeneca and Daiichi Sankyo’s antibody-drug conjugate Enhertu significantly improved progression-free survival in metastatic breast patients with low and ultralow HER2 expression levels who had received at least one line of systemic treatment.
Ono to buy Deciphera for $2.4B, looks to expand cancer pipeline and US footprint
/in Therapeutics/by BioSpaceOno Pharmaceutical said Monday it will pay $2.4 billion to acquire Deciphera Pharmaceuticals for cancer drugs that could generate peak annual sales of more than $1 billion.
Real Chemistry introduces IRIS: a platform for delivering insights on obesity market and GLP-1 therapies
/in Marketing & Advertising/by AdministratorIRIS offers immersive insights reports and live dashboards designed to help the healthcare industry and other stakeholders anticipate and identify transformative market events, and how best to strategically navigate the fast-moving environment.
AI powers successes
/in April 2024, Healthcare Communications Agencies, Healthcare Communications Agencies, Issue Archives, Marketing & Advertising, Special Reports/by Christiane Truelove2023 was definitely a busy year for many agencies as the world continued to move on from the pandemic. Despite economic headwinds, several of the agencies featured in this issue reported growth and an increase in the number of their clients and accounts held. The other commonality noted in these profiles was an unhesitating attitude towards the adoption of generative and analytical AI tools for themselves and their clients, leading to new opportunities.
Med Ad News 2024 Industry Person of the Year: Ken Begasse Jr.
/in April 2024, Healthcare Communications Agencies, Issue Archives, Manny Awards, Marketing & Advertising/by Administrator“Ken embodies the essence of leadership, not just through his actions but through his unwavering commitment to do better … to be better. Ken embodies a culture of continuous learning and development, encouraging each member of our team to reach their full potential.”
Med Ad News 2024 Marketer on the Rise: Sarah Hansen
/in April 2024, Healthcare Communications Agencies, Issue Archives, Manny Awards, Marketing & Advertising/by AdministratorSarah Hansen is associate director, US Patient Marketing Metabolics, Alexion. She was nominated by Snow Companies.